Health economic evaluation of an integrated, cross-sectorial psycho-oncology - WP Health economic evaluation for the study Integrated, cross-sectorial psycho-oncology (isPO)

• Conditions: C00-C97; Malignant neoplasms

• Registration Number: DRKS00022396
• Lead Sponsor: niversitätsklinikum Köln, Klinik I für Innere Medizin, Klinische Psychoonkologie, Versorgungsforschung / isPO-Konsortialführung

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-09-08
• Study Completion: 2021-09-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 423

Inclusion Criteria

IG:
• patients with an initial diagnosis cancer participating in the new form of care isPO
• insured with the participating data-providing statutory health insurance companies BARMER, TK, AOK Rheinland/Hamburg or DAK Gesundheit
• included isPO patients in the study until 30.09.2019. The sample group is a subgroup of the IG of the isPO research project. The procedure is justified by the time delay and availability of SHI claims data. Only completely provided data sets of isPO participants within the project duration can be considered for evaluation.

CG:
• insured persons with an initial diagnosis cancer who do not participate in isPO care and are treated in standard care
• insured with the participating data-providing statutory health insurance companies BARMER, TK, AOK Rheinland/Hamburg or DAK Gesundheit

Observation-/ Evaluation period:
• from the defined index date (IG: enrolled date in isPO, KG: date of coded assured initial diagnosis of cancer based on routine SHI database), costs and consequences are descriptively evaluated over a period of 12 months using SHI claims data.

Exclusion Criteria

• no age of majority at baseline (age < 18 years)
• not insured with the participating data-providing statutory health insurance companies BARMER, TK, AOK Rheinland/Hamburg or DAK Gesundheit
• IG: enrolement in isPO care after 30.09.2019 (enrolement date >=01.10.2019)
• CG: Non-fulfilment of the selection criteria of the comparison group from standard care (observation period, cancer diagnosis, gender, age, region) and other covariates for the application of a propensity score matching

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quantification of the costs and consequences of the intervention of patients in the isPO programme compared to patients in standard care from the SHI perspective.<br><br>Evaluation based on SHI claims data:<br>costs, for example inpatient cost, outpatient cost<br>consequences, for example number of hospitalisation, physicians' contacts<br><br>Evaluation period: <br>12 months from the defined baseline date (IG: enrolement date in the isPO care program, CG: date of assured initial diagnosis of cancer [diagnostic coding])